Trial
NCT03179605
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Primus Pharmaceuticals
Collaborators
Prosoft Clinical
Condition
Psoriasis
Intervention
DFD06
Why stopped
Difficulty in enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-07